恶性梗阻性黄疸双介入治疗的临床应用

The Result of Percutaneous A Double Interventional Therapy for Malignant Biliary Obstruction

目的:总结双介入治疗恶性梗阻性黄疸的临床疗效.材料与方法:恶性梗阻性黄疸患者13例.年龄58～77岁,PTCD术后均留置内支架,后行TAIC治疗.比较手术前后血清胆红素变化情况及统计生存时间.结果:治疗后血清胆红素明显下降,全部病例生存时间为6个月、12个月、18个月、24个月、36个月分别为84.6%(11/13)、61.54%(8/13)、46.15%(6/13)、30.77%(4/13)、15.38%(2/13).结论:PTCD术后置入内支架结合TAIC治疗恶性梗阻性黄疸疗效好,确能提高患者生命质量,延长生存期.

Purpose.： To analyze the Value of percutaneous a double interventional therapy in malignant biliary obstruction. Materials and Methods： 13 cases with malignant obstruction jatmdice were treated percutaneously. In all the patients, drainage catheters were implanted firsdy, then bile duct stent tubes were deployed. In all the patients, Underwent transcatheter infusion chemotherapy （TAIC）. The value of serun bilirulin of pre and post - treatment were recorded; the average survival time （AST） group. Results： All patients underwent PTCD and TAIC successfully, In the experimenta lgroup, 0.5, 1, 1.5, 2, 3 year stu＇vival rate were 84.62% （11/13）, 61.54% （8/13）, 46.15% （6/ 13）, 30.77% （4/13）, 15.38% （2/13） respectively. Conclusion： Percutaneous a double interventional therapy in malignant biliary obstruction, which is more effective in increasing the survival rate.